Page last updated: 2024-10-20

pyrazinamide and Connective Tissue Disease, Mixed

pyrazinamide has been researched along with Connective Tissue Disease, Mixed in 1 studies

pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.

Research Excerpts

ExcerptRelevanceReference
"appearance of a bilateral bacillary pulmonary tuberculosis with a severe involvement of the right lung."2.40[Sharp syndrome complicating pulmonary tuberculosis: apropos of a case]. ( Ba, O; Cissokho, S; Diatta, A; Dieng, MT; Hane, AA; Kandji, M; Ndiaye, B; Ndiaye, M; Ndir, M; Niang, A, 1999)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ndiaye, M1
Hane, AA1
Dieng, MT1
Ndir, M1
Ba, O1
Cissokho, S1
Kandji, M1
Diatta, A1
Niang, A1
Ndiaye, B1

Reviews

1 review available for pyrazinamide and Connective Tissue Disease, Mixed

ArticleYear
[Sharp syndrome complicating pulmonary tuberculosis: apropos of a case].
    Dakar medical, 1999, Volume: 44, Issue:2

    Topics: Adrenal Cortex Hormones; Adult; Antibodies, Antinuclear; Antitubercular Agents; Autoimmune Diseases;

1999